The Company's line of plant and mushroom-based natural health products will be available at LCL grocery banners across Canada HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the " Company " or " HAVN Life ") announces that the board of directors of the Company (the " Board "), on the advice of the Company's Chief Financial Officer, has determined that the Company is no longer a going concern as it is unable to meet its financial obligations as they come due. A restructuring plan is being put together by the Board, and the Company is... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company” or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it will complete a consolidation (“ Consolidation ”) of its issued and outstanding common shares ‎on the basis of one (1) post-consolidation common share for every thirty (30)... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that Alpha Blue Ocean (" ABO ") is supporting the Company's growth with a CAD$‎‎9,000,000 ‎‎financing arrangement whereby the Company will issue up to $10.6 million principal amount... Read More

This new partnership will see the distribution of the Company's standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Healing Escapes Foundation retreats in Jamaica HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is... Read More

The Company's segment will be aired on public television networks across the U.S. starting in July, with interviews featuring CEO Tim Moore and the team leading HAVN Life's Research and Development HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the " Company " or " HAVN Life ") announces the departure of Messrs. Victor Neufeld and Dennis Staudt , respectively, as Directors of the Company (" Board "), effective immediately. The Company expresses its appreciation for Mr. Neufeld and Mr. Staudt's services to the Company and wishes them the very best. Stated Mr. Neufeld, "Both Dennis and myself have enjoyed... Read More

This new partnership will see the distribution of The Company's standardized, naturally derived, psilocybin containing mushrooms to local Jamaican dispensaries for legal sale HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it has... Read More

Havn Life Sciences Inc. (CSE: HAVN ) (OTC Pink: HAVLF ) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and cognitive function, is announcing that CEO, Tim Moore will be presenting at the LD Micro Invitational XII , taking place June 7-9, 2022 at the Four Seasons Westlake Village in California, with... Read More

Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a... Read More

This new partnership will see the distribution of the Company's standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Atman retreats in Jamaica HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it... Read More

The successful shipment of white label natural health products will expand the Company's global retail footprint HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or " HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health... Read More

HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP) , a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential APIs to support brain health and cognitive function, today announced that it will be presenting at the Planet MicroCap Showcase 2022 at the Bally's Hotel & Casino in Las Vegas, NV on Wednesday, May 4, 2022 at 9:00 a.m. PST. Tim Moore, CEO of... Read More

The expanded partnership to include the distribution of functional mushrooms, HAVN Life natural health products and white label products, in addition to its naturally-derived psilocybin compounds HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased... Read More

With this deal, The Company's full line of natural health formulations will now be available across Canada at select health food store locations HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it has secured a distribution deal... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is pleased to announce that it has closed its previously announced sale of units to U.S. institutional investors, for gross proceeds of approximately C$2,000,000 , on a private placement basis in the... Read More

The Company's full line of natural health formulations will be available at select locations starting in May HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it has secured a product listing agreement with Calgary Co-op for the... Read More

CEO Tim Moore will share recent partnership and distribution news and a roadmap for the Company's plans for the next quarter Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and cognitive function, is announcing that CEO Tim Moore will be presenting at... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and cognitive function, is pleased to announce that it has entered into a securities purchase agreement with certain U.S. institutional investors for a private placement of 22,988,506 of its common shares... Read More

EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 26 th Emerging Growth Conference. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall... Read More

The Company continues to grow its global retail footprint by partnering with the world's largest ecommerce site HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is pleased to announce that its portfolio of natural health products is now available... Read More

HAVN Life Sciences Inc. (CSE: HAVN ) (OTC: HAVLF ) (FSE: 5NP ) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential APIs to support brain health and cognitive function, is pleased to announce it has successfully secured a purchase order for naturally derived psilocybin from their Canadian supply partner, Revive Therapeutics... Read More

Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, announces that the amalgamation agreement entered into with Spore Life Sciences Inc. (" Spore "), as announced on December 20, 2021 , has terminated, and the transactions contemplated thereby are not... Read More

The Agreement allows HAVN Life to export naturally derived psilocybin from its Jamaica facility and grows roster of supply partners in the U.S. market HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential APIs to support brain health and cognitive function, is... Read More

Tim Moore and Michael Zavet to speak on Thursday, January 27 at 4:25pm EST HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, is announcing that CEO Tim Moore will be hosting a virtual session at the upcoming... Read More

Mr. Leong brings with him a wealth of scientific and regulatory experience HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) ( the "Company" or "HAVN Life" ), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is pleased to announce the appointment of Mr. Gary Leong to its Board of Directors. Concurrently, Mr. Leong... Read More

The Subscription-based Functional Mushroom Company has established a significant consumer base in the U.S. Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative therapies to support central nervous system health and enhance the capabilities of the mind, is pleased to announce it has entered into a definitive... Read More

The Company was able to export naturally derived psilocybin to their California -based Supply Partner, Mycrodose Therapeutics late last week. Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential active pharmaceutical ingredients (APIs) to support brain health, is... Read More

CEO Tim Moore to present and host a Q & A for investors on December 8 at 2:30pm EST Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, is announcing that CEO Tim Moore will be presenting at the SNN Network Canada... Read More

The Company Signs Supply Agreement with Nectar Health Sciences Laboratory Division Inc. to provide naturally derived psilocybin for research and development of therapeutic products Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction... Read More

Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today it has initiated plans for a psilocybin-based pharmaceutical program by entering into an agreement to form a 50/50 joint venture (the “Joint Venture”) with Agile Pharmaceutical Solutions to develop novel oral dosage forms of psilocybin in the form of a... Read More

The Agreement gives Woke Pharmaceuticals exclusive White Label and Distribution rights to HAVN Life products in Australia , New Zealand and China through retail and e-commerce portals HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is... Read More

HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP) (the " Company " or " HAVN Life ") announces the departure of Mr. Rick Brar as Vice-Chair of the board of directors of the Company (" Board ") and as a director of the Company, effective immediately. The Company expresses its appreciation for Mr. Brar's services to the Company and wishes him well in his future endeavours. On behalf of the Board, Mr. Vic Neufeld ,... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the " Company " or " HAVN Life ") announces that it has been granted an extension of six months by the Registrar of Companies, to hold its first Annual General Meeting under section 182(4) of the Business Corporations Act ( British Columbia ). The six months extension is from October 8, 2021 , to April 8, 2022 . About HAVN Life Sciences Inc. HAVN Life Sciences is a... Read More

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") is pleased to announce that it has filed its final short form base shelf prospectus (the " Final Shelf Prospectus ") with the securities commissions in each of the provinces and territories of Canada and received a final receipt in respect thereof. The Final Shelf Prospectus allows the Company to offer and issue up to $25,000,000 of... Read More

Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") provides an update on its operations. On August 3, 2021 , the Company announced it had harvested its first crop of psilocybin-containing mushrooms (the " Products ") from its operations in Jamaica , and that the Company would be exporting the harvested psilocybin to Canada for safety and quality control testing by its lab partner,... Read More

Along with adding new formulations to the Company's natural health product portfolio, founder Matthew Bennett to join HAVN Life as Director of Education Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind is pleased to announce that is has... Read More

The partnership is a integral step in the The Company's path to market in the U.S., achieving one of its most important milestones to-date Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, is thrilled to... Read More

Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of active pharmaceutical ingredients that support brain health and enhance the capabilities of the mind, is pleased to announce their partnership with Horizon Grocery + Wellness , Western Canada's leading distributor of organic and... Read More

The partnership will further industry growth for naturally derived psilocybin Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, recently signed an agreement to supply naturally-derived psilocybin to Mycotopia... Read More

Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the “Company”), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin Supply Agreement with Havn Life Sciences (CSE: HAVN) (OTC Pink: HAVLF). The terms of the agreement call for Havn Life Sciences to supply Mycotopia Therapies with naturally-derived psilocybin. Under the terms of the agreement, Mycotopia Therapies is classified as a specialty... Read More

Havn Life Sciences Inc. (CSE: HAVN ) (OTC Pink: HAVLF ) (FSE: 5NP ) (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind today announced that it will be presenting at the upcoming Q3 Investor Summit Virtual Conference. Details of the presentation are below. WHO: Tim Moore, Havn Life Sciences - CEO... Read More

HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common Market to export psilocybin. HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "HAVN Life''), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the... Read More

With FBA designation, the Company continues to grow its retail footprint by partnering with the world's largest ecommerce site Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life") a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is pleased to announce it has received FBA designation... Read More

The Agreement with P.A. Benjamin Manufacturing Company whom operates a GMP compliant facility in Jamaica Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FRA:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and enhance the capabilities of the mind, is thrilled to announced a new agreement with P.A.... Read More

The Company will supply naturally-derived psilocybin for the development of psilocybin microdosing health products Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is announcing a new supply agreement with Cube Psytech, a biopharmaceutical and... Read More

The Agreement will utilize HAVN Life's fully integrated supply chain model, from the growing of psilocybin through to extraction, compounding, and encapsulation HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is thrilled to announce it has entered... Read More

Newly-launched line of natural health products to be available at all locations later this month HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it has secured a product listing agreement with Choices Markets for the company's... Read More

Seven new formulations that support brain health and immune function will be available online and at select retail locations starting June 3 Mind Mushroom , Bacopa Brain , Rhodiola Relief , Cordyceps Perform , Chaga Immunity , Reishi Recharge and Lion's Mane —are now available at yourHAVNlife.com and will be rolling out on Amazon and at select Nesters Market stores across British Columbia later this month. Designed to... Read More

The Company will seek Orphan Drug Designation to significantly reduce time to market HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce the completion of the previously announced acquisition of clinical stage intellectual... Read More

Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a production and supply agreement (the "Agreement") with Lobe Sciences Ltd. (LOBE) (GTSIF),... Read More

HAVN Life works towards substantiating a patent application and preclinical work HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it has entered into a definitive agreement to acquire clinical stage intellectual property... Read More

Havn Life will join 80+ other small cap and micro-cap companies at leading event for investors Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that CEO Tim Moore will attend the Q2 Virtual Investor Summit. The event, scheduled... Read More

Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce it has entered into a supply agreement (the "Supply... Read More

Havn Life has completed its analytical work under its Health Canada Section 56 exem ption Havn Life Sciences Inc. (CSE: HAVN ) (OTC PINK: HAVLF ) (FSE: 5NP ) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it has completed the analytical work under its Health Canada Section 56... Read More

The Company has started production of its first grow with local partner Hypha Wellness Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it now has a fully operational mycology lab and production facility in Jamaica. By... Read More

The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce, further to its news release dated January 26, 2021,... Read More

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, has entered into a letter of intent... Read More

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will be presenting virtually at the upcoming Zooming with LD event on Wednesday, March 24th 2020 at... Read More

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that industry veteran Jenna Pozar is joining the team as Chief Operating Officer. Mrs. Pozar brings... Read More

Attendees will have the opportunity to get the latest updates and participate in Q & A with Havn Life's CEO Tim Moore Havn Life Sciences Inc. (CSE: HAVN )(OTC PINK: HAVLF )(FSE: 5NP ) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will host a webcast investor presentation on... Read More

Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce today that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States. The Company's common... Read More

Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or "Havn Life"), announces the departure of Ms. Barinder Rasode as President and as a director of the Company, effective immediately. The Company also announces that its Chief Executive Officer, Mr. Tim Moore, has been appointed as a director of the Company. Ms. Rasode commented, "We created Havn Life to benefit human health and harness the medicine... Read More

Havn Life to supply psychedelic compounds for clinical trials launched by neuroscience and technology leader HealthTech Connex Havn Life Sciences Inc. (CSE: HAVN )(OTC PINK: HAVLF )(FSE: 5NP ) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce a strategic partnership with neuroscience and... Read More

The acquisition is intended to vertically integrate the Company's retail manufacturing capabilities to support the growth of its nutraceutical division and deliver unique products to consumers Havn Life Sciences Inc. (CNSX: HAVN ) (OTC PINK: HAVLF ) (FSE: 5NP ) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products,... Read More

Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it will be included in the First Psychedelics Exchange Traded Fund ("ETF"). The ETF will begin traded on the Neo Exchange on January 26, 2021. Havn Life is one of seventeen... Read More